Mandelia Ashish
VP, Chief Accounting Officer at Mersana Therapeutics, Inc.
- Sold, on record
- $173k
- Dollars the filings state
- Form 4 sales
- 11
- Latest Jan 16, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mersana Therapeutics, Inc.VP, Chief Accounting Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Mersana Therapeutics, Inc.UnusualJul 1, 2021 2021
Sold 942 shares at $13.60 ($13k)
Mandelia Ashish, VP, Controller
Sold 100% of holdings ($13k position)0 shares left1.7x usual sizeFiling
- 2 Form 4 sale Mersana Therapeutics, Inc.UnusualJan 18, 2022 +201 days
Sold 1,982 shares at $5.92 ($12k)
Mandelia Ashish, VP, Controller
Sold 37% of holdings ($32k position)3,371 shares left2.7x usual sizeFiling
- 3 Form 4 sale Mersana Therapeutics, Inc.UnusualJan 17, 2023 +364 days
Sold 3,575 shares at $5.74 ($21k)
Mandelia Ashish, VP, Controller
Sold 20.8% of holdings ($99k position)13,619 shares left3.8x usual sizeFiling
- 4 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2024 +364 days
Sold 5,025 shares at $2.71 ($14k)
Mandelia Ashish, VP, Chief Accounting Officer
10b5-1 planSold 17.7% of holdings ($77k position)23,328 shares leftFiling
- 5 Form 4 sale Mersana Therapeutics, Inc.RoutineOct 3, 2024 +261 days
Sold 8,216 shares at $1.98 ($16k)
Mandelia Ashish, VP, Chief Accounting Officer
10b5-1 planSold 14.7% of holdings ($111k position)47,757 shares leftFiling
- 6 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 14, 2025 +103 days
Sold 1,007 shares at $0.66 ($665)
Mandelia Ashish, VP, Chief Accounting Officer
10b5-1 planSold 2% of holdings ($33k position)49,396 shares left0.2x usual sizeFiling
- 7 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 15, 2025 +1 day
Sold 1,791 shares at $0.63 ($1k)
Mandelia Ashish, VP, Chief Accounting Officer
10b5-1 planSold 3.3% of holdings ($34k position)52,388 shares left0.4x usual sizeFiling
- 8 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2025 +1 day
Sold 3,554 shares at $0.58 ($2k)
Mandelia Ashish, VP, Chief Accounting Officer
10b5-1 planSold 5.8% of holdings ($35k position)57,519 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Form 4 sale | 3,554 | $2k | 5.8% | Routine | SEC |
| Jan 15, 2025 | Jan 16, 2025 | Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Form 4 sale | 1,791 | $1k | 3.3% | Routine | SEC |
| Jan 14, 2025 | Jan 15, 2025 | Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Form 4 sale | 1,007 | $665 | 2.0% | Routine | SEC |
| Oct 3, 2024 | Oct 7, 2024 | Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Form 4 sale | 8,216 | $16k | 14.7% | Routine | SEC |
| Jan 16, 2024 | Jan 17, 2024 | Mersana Therapeutics, Inc. | VP, Chief Accounting Officer | Form 4 sale | 5,025 | $14k | 17.7% | Routine | SEC |
| Jan 17, 2023 | Jan 18, 2023 | Mersana Therapeutics, Inc. | VP, Controller | Form 4 sale | 3,575 | $21k | 20.8% | Unusual | SEC |
| Jan 18, 2022 | Jan 19, 2022 | Mersana Therapeutics, Inc. | VP, Controller | Form 4 sale | 1,982 | $12k | 37.0% | Unusual | SEC |
| Jul 1, 2021 | Jul 2, 2021 | Mersana Therapeutics, Inc. | VP, Controller | Form 4 sale | 942 | $13k | 100.0% | Unusual | SEC |
| Jan 19, 2021 | Jan 20, 2021 | Mersana Therapeutics, Inc. | VP, Controller | Form 4 sale | 545 | $12k | 100.0% | Unusual | SEC |
| Jan 4, 2021 | Jan 6, 2021 | Mersana Therapeutics, Inc. | VP, Controller | Form 4 sale | 247 | $7k | 100.0% | Unusual | SEC |
| Jul 2, 2020 | Jul 6, 2020 | Mersana Therapeutics, Inc. | VP, Controller | Form 4 sale | 3,383 | $76k | 100.0% | Unusual | SEC |